Meeting
2017 ASCO Annual Meeting
A randomized phase II trial of consolidation chemotherapy after preoperative chemoradiation (preop CRT) versus CRT alone for locally advanced rectal cancer (LARC).
Authors
Sun Young Kim
Center for Colorectal Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Republic of Korea
Sun Young Kim , Tae Won Kim , Yong Sang Hong , Jeong Eun Kim , Keun Wook Lee , Ji-Won Kim , In Gyu Hwang , Beom Gyu Kim , Joong Bae Ahn , Ho-Suk Oh , Dae Young Zang , Jungnam Joo , Dae Yong Kim , Jae Hwan Oh , Ji Yeon Baek
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal (Colorectal) Cancer
Track
Gastrointestinal Cancer—Colorectal and Anal
Sub Track
Colorectal Cancer–Local-Regional Disease
Clinical Trial Registration Number
NCT01952951
Citation
J Clin Oncol 35, 2017 (suppl; abstr 3606)
DOI
10.1200/JCO.2017.35.15_suppl.3606
Abstract #
3606
Poster Bd #
229
Abstract Disclosures
Similar Posters
Poster
2014 Gastrointestinal Cancers Symposium
Chemoradiation (CRT) followed by surgery and adjuvant capecitabine plus oxaliplatin (CAPOX) compared with induction CAPOX followed by concomitant CRT and surgery for locally advanced rectal cancer: Results of the Spanish GCR-3 randomized phase II trial after a median follow-up of 5 years.
First Author: Carlos Fernandez-Martos
Poster
2022 ASCO Gastrointestinal Cancers Symposium
SONCAR study: A prospective randomized controlled study on optimized neoadjuvant chemotherapy-oxaliplatin plus CRT in patients with locally advanced rectal cancer.
First Author: Rong-Xin Zhang
Poster
2021 Gastrointestinal Cancers Symposium
Short-course radiotherapy and subsequent CAPOX plus camrelizumab followed by delayed surgery for locally advanced rectal cancer: Short-term results of a phase II trial.
First Author: Zhenyu Lin
Poster
2023 ASCO Annual Meeting
Total neoadjuvant treatment without surgery for locally advanced rectal cancer: Prospective study to assess tumor response, circulating genetic, and epigenetic biomarkers, and stromal transcriptome to interpret clinical outcome (NO-CUT trial).
First Author: Salvatore Siena